Assuntos
Acidentes por Quedas/prevenção & controle , Desprescrições , Registros Eletrônicos de Saúde , Epilepsia/tratamento farmacológico , Registro Médico Coordenado , Conduta do Tratamento Medicamentoso , Fenitoína , Idoso , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/efeitos adversos , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Informação em Farmácia Clínica/normas , Prescrições de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Registros Eletrônicos de Saúde/organização & administração , Registros Eletrônicos de Saúde/normas , Prescrição Eletrônica/normas , Feminino , Humanos , Levetiracetam/administração & dosagem , Registro Médico Coordenado/métodos , Registro Médico Coordenado/normas , Conduta do Tratamento Medicamentoso/organização & administração , Conduta do Tratamento Medicamentoso/normas , Fenitoína/administração & dosagem , Fenitoína/efeitos adversos , Padrões de Prática MédicaAssuntos
Pesquisa Biomédica/tendências , Sistemas de Informação em Farmácia Clínica/tendências , Setor de Assistência à Saúde/tendências , Farmacogenética/tendências , Medicina de Precisão/tendências , Pesquisa Biomédica/normas , Sistemas de Informação em Farmácia Clínica/normas , Setor de Assistência à Saúde/normas , Humanos , Farmacogenética/normas , Medicina de Precisão/normasRESUMO
BACKGROUND: The American College of Clinical Pharmacy (ACCP) prepared clinical pharmacist competencies that have specific recommendations. Recently, many efforts to advance clinical pharmacy services in Egypt exist. The literature revealed that no country has assessed the extent of applicability of ACCP competencies in its current pharmacy practice setting. Egyptian pharmacists can provide feedback about applicability of such competencies in clinical pharmacy settings in Egypt. OBJECTIVE: The objective of this study was to investigate the extent to which ACCP competencies were implemented by Egyptian clinical pharmacists and therefore evaluate development of clinical pharmacy practice in Egypt. The study also investigated factors affecting the applicability of such competencies in the current clinical pharmacy practice setting in Egypt. METHODS: Four hundred and ninety-five randomly selected clinical pharmacists from several hospitals were invited to participate in a cross sectional survey using a self-administered validated questionnaire composed of 31 questions classified into six domains. This questionnaire was designed to determine the pharmacists' perception about applicability of ACCP competencies to clinical pharmacy practice in Egypt. RESULTS: The response rate was 64% as 317 out of 495 pharmacists completed the questionnaire. These pharmacists were categorized according to age; gender; qualifications; years of previous work experience, years since BSc. and type of hospitals they are currently working at. Analysis of data revealed the professionalism domain to have the highest percentage of acceptance among pharmacists, while the system-based care & population health domain had the lowest percentage of acceptance. Results also showed that qualifications of participants did not affect their response in three domains; "Direct Patient Care", "Systems-based Care & Population Health" and "Continuing Professional Development" (p = 0.082, 0.081, 0.060), respectively. Nevertheless, qualifications of participants did affect their response in the other three domains; "Pharmacotherapy Knowledge", "Communication" and "Professionalism" (p < 0.05). The age of pharmacists, gender, years of previous work experience, and graduation year did not affect their responses in all six domains. The type of hospital they are currently working at, though, affected their responses where, there was a highly statistically significant increase of the mean score of all domains among participants working at the NGOs/private hospitals compared to governmental hospitals (p < 0.001). CONCLUSIONS: Egyptian pharmacists generally apply high percentage of ACCP competencies but the provided clinical pharmacy services need to be improved through applying the standards of best practice
No disponible
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Conselhos de Especialidade Profissional/normas , Prática Profissional , Profissionalismo , Egito , Sistemas de Informação em Farmácia Clínica/normas , Inquéritos e Questionários , Competência Profissional/normas , Estudos TransversaisRESUMO
BACKGROUND: There are serious safety risks associated with chemotherapy, often associated with interdependencies in regimens administered over months or years. Various strategies are used to manage these risks. Computerized provider order entry (CPOE) systems are also implemented to improve medication safety. Little is known regarding the effect of CPOE on how clinicians manage chemotherapy interdependencies and their associated safety strategies. METHODS: We conducted a multi-method qualitative study in a paediatric hospital. We analysed 827 oncology incidents reported following CPOE implementation and carried out semi-structured interviews with doctors (n = 10), nurses (n = 6), a pharmacist, and oncology CPOE team members (n = 2). Results were interpreted according to safety models (ultra-safe, high-reliability organisations [HROs], or ultra-adaptive). RESULTS: Incident reports highlighted two interrelated types of interdependencies: those within organisation of clinical activities and those inherent in chemotherapy regimens. Clinicians reported strategies to address chemotherapy risks and interdependencies. These included rigid rules and 'no go' contexts for treatment to proceed, typical of the ultra-safe model; use of time (e.g. planning only so far ahead) and sensitivity to operations, typical of HROs. We identified three different time horizons in CPOE use in relation to patients' treatments: life-long, the whole regimen, and the 'here and now'. CPOE supported ultra-safe strategies through automation and access to rules/standardisation, but also created difficulties and contributed to incidents. It supported the 'here and now' better than a life-long or whole regimen view of a patient treatment. Sensitivity to operations was essential to anticipate and resolve uncertainties, hazards, CPOE limitations, and mismatches between CPOE processes and workflow in practice. CONCLUSIONS: Within oncology, CPOE appears to move the 'mix' of risk strategies towards ultra-safe models of safety and protocol-mandated care. However, in order to operate ultra-safe strategies embedded in CPOE and stay on protocol it is essential for clinicians to be thoughtful and show sensitivity to operations in CPOE use. CPOE design can be advanced by better consideration of mechanisms to support interdependencies.
Assuntos
Antineoplásicos/uso terapêutico , Sistemas de Informação em Farmácia Clínica/normas , Sistemas de Apoio a Decisões Clínicas/normas , Hospitais Pediátricos/estatística & dados numéricos , Sistemas de Registro de Ordens Médicas , Neoplasias/tratamento farmacológico , Antineoplásicos/administração & dosagem , Criança , Humanos , Pesquisa Qualitativa , Reprodutibilidade dos Testes , Fluxo de TrabalhoRESUMO
PURPOSE: Risks and vulnerabilities of the medication-use process in nonpediatric institutions that also serve pediatric patients are reviewed, and guidance on risk mitigation strategies is provided. SUMMARY: There are many risks and vulnerabilities in the medication-use process as it relates to pharmacotherapy for pediatric patients admitted to adult institutions. Mitigation of these risks is critical and should encompass various available resources and strategies. Special emphasis should be placed on use of technology to improve overall safety. Available literature recommends optimization of technology and resource use, institutional support for pediatric pharmacists' involvement in managing pediatric medication use, and provision of early exposure to pediatric patients in pharmacist training programs as additional methods of mitigating risks associated with pediatric medication use in adult institutions. Adult hospitals that provide care for pediatric patients should assess their processes in order to identify hospital-specific interventions to promote pediatric medication safety. CONCLUSION: Pediatric medication safety frameworks in U.S. adult institutions vary widely. Treating pediatric patients involves risks in all areas of the medication-use process. Optimizing technology, utilizing external resources, supporting a pediatric pharmacist, and providing early-career exposure to pediatric patients are methods to mitigate risks in institutions that primarily serve adult patients.
Assuntos
Erros de Medicação/prevenção & controle , Conduta do Tratamento Medicamentoso/organização & administração , Farmacêuticos/organização & administração , Serviço de Farmácia Hospitalar/organização & administração , Gestão da Segurança/normas , Adulto , Fatores Etários , Criança , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Informação em Farmácia Clínica/normas , Composição de Medicamentos/normas , Cálculos da Dosagem de Medicamento , Educação em Farmácia , Educação Continuada em Farmácia , Humanos , Sistemas de Registro de Ordens Médicas/organização & administração , Sistemas de Registro de Ordens Médicas/normas , Conduta do Tratamento Medicamentoso/normas , Farmacêuticos/normas , Serviço de Farmácia Hospitalar/normas , Guias de Prática Clínica como Assunto , Papel ProfissionalRESUMO
Background The introduction of new technologies in the prescribing process has seen the emergence of new types of medication errors. Objective To determine the prevalence and consequences of technology-induced prescription errors associated with a computerized provider order entry (CPOE) system in hospitalized older patients. Setting Patients 65 years or older admitted to the Departments of Internal Medicine, General Surgery, and Vascular Surgery of a tertiary hospital. Method Prospective observational 6-month study. Technology-induced errors were classified according to various taxonomies. Interrater reliability was measured. Consequences were assessed by interviewing patients and healthcare providers and classified according to their severity. Main outcome measure Prevalence of technology-induced errors. Results A total of 117 patients were included and 107 technology-induced errors were recorded. The prevalence of these errors was 3.65%. Half of the errors were clinical errors (n = 54) and the majority of these were classified as wrong dose, wrong strength, or wrong formulation. Clinical errors were 9 times more likely to be more severe than procedural errors (14.8 vs 1.9%; OR 9.04, 95% CI 1.09-75.07). Most of the errors did not reach the patient. Almost all errors were related to human-machine interactions due to wrong (n = 61) or partial (n = 41) entries. Conclusion Technology-induced errors are common and intrinsic to the implementation of new technologies such as CPOE. The majority of errors appear to be related to human-machine interactions and are of low severity. Prospective trials should be conducted to analyse in detail the way these errors occur and to establish strategies to solve them and increase patient safety.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Sistemas de Registro de Ordens Médicas/normas , Erros de Medicação/prevenção & controle , Software/normas , Idoso , Idoso de 80 Anos ou mais , Sistemas de Informação em Farmácia Clínica/tendências , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/diagnóstico , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Feminino , Geriatras/normas , Geriatras/tendências , Humanos , Masculino , Sistemas de Registro de Ordens Médicas/tendências , Erros de Medicação/tendências , Farmacêuticos/normas , Farmacêuticos/tendências , Estudos Prospectivos , Software/tendências , Centros de Atenção Terciária/normas , Centros de Atenção Terciária/tendências , Interface Usuário-ComputadorRESUMO
BACKGROUND: Despite the benefits of improving transitions across care, literature is very limited on inpatient "Communication about Medicines" (ComMed) by staff across United States (U.S.) hospitals. OBJECTIVES: To evaluate ComMed quality variations by hospital characteristics. METHODS: In a cross-sectional, retrospective study of publicly available U.S. Medicare's Hospital Consumer Assessment of Health Care Plans Survey (HCAHPS) data (January 2013-September 2014), ComMed quality (high = above average/excellent vs. low = average/below average/poor star ratings) of 3125 hospitals were compared across region, rural-urban location, and health information technology (HIT) infrastructure giving providers access to patients' electronic medical records. Multivariate logistic regression analysis was conducted with adjusting for confounders (hospital - bed size, ownership, type, ED services, the number of completed HCAHPS surveys). RESULTS: After adjusting for other characteristics, Midwest versus Western region hospitals (OR = 1.55, 95% CI: 1.21-1.98, p=<0.0001), hospitals with HIT infrastructure (OR = 1.29, 95% CI: 1.05-1.59, p = 0.02) were more likely while Northeast vs. Western region hospitals (OR = 0.67, 95% CI: 0.50-0.89, p=<0.0001) and hospitals in metropolitan areas with 1 million or more population vs. Nonmetro area with less than 2500 population were less likely (OR = 0.68, 95% CI: 0.48-0.95, p=<0.0001), to be associated with high ComMed quality. Hospitals' small bed-size, physician/non-profit ownership, critical-access type, absent ED services, and 100-299 HCAHPS completed surveys were more likely to be associated with high ComMed quality. CONCLUSIONS: One of the first national studies found significant variations in ComMed quality across U.S. hospitals by location (high in Midwest and low in Northeast regions and urban areas) and by access to HIT infrastructure (high) after controlling for other hospital characteristics. With this baseline data, hospital providers and policymakers can design, implement, and evaluate service programs with pharmacists and HIT to enhance ComMed quality in the future delivery of patient-centered care.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Comunicação , Disparidades em Assistência à Saúde/normas , Hospitais/normas , Farmacêuticos/normas , Serviço de Farmácia Hospitalar/normas , Relações Profissional-Paciente , Indicadores de Qualidade em Assistência à Saúde/normas , Distribuição de Qui-Quadrado , Humanos , Modelos Logísticos , Análise Multivariada , Razão de Chances , Satisfação do Paciente , Assistência Centrada no Paciente/normas , Estudos Retrospectivos , Estados UnidosRESUMO
Objetivos: Listar las variables imprescindibles en los cuadros de mando integrales para abarcar todas las áreas básicas de trabajo en una Unidad de Radiofarmacia hospitalaria, cuya adecuada gestión puede ser clave para optimizar los recursos disponibles. En segundo lugar, enumerar los beneficios que redundan en la práctica de trabajo diario tras su integración. Métodos: Revisión de la bibliografía publicada sobre cuadros de mando integrales, seleccionando las variables para que el radiofarmacéutico asuma un papel activo en la mejora de su área de trabajo. Se utilizan programas construídos en Microsoft Access para la gestión integral. Se administran en varios módulos toda la información desde la prescripción y citación de los pacientes (asignándoles un código) hasta que se les realiza la exploración. Se recogen también variables como: fecha y hora límites de tramitación de radiofármaco al proveedor; fecha prueba médica; gestión de eluciones de generadores y kits fríos; turnos de trabajo del personal; registro de incidencias tipificadas y de datos de recepción, marcaje, control de calidad y dispensación de cada radiofármaco (asegurando la trazabilidad); detección de desviaciones entre actividad calibrada y medida; la actividad dispensada y la disponible a tiempo real; gestión de eliminación de residuos radiactivos, de existencias y caducidades; fechas de próximas revisiones de equipos; archivado de PNT; sistemas conversores de unidades y registro de informes clínicos. Resultados: Los programas especializados gestionan la información que se maneja en la Unidad de Radiofarmacia, facilitando tomar decisiones coste-efectivas. Los parámetros analizados son: número de preparaciones elaboradas y actividad manejada; posibles incidencias en cualquiera de los procesos cotidianos; porcentaje de resolución satisfactoria sin que derive en falta de disponibilidad; correcta trazabilidad de los radiofármacos; porcentaje de controles de calidad satisfactorios; evolución en el consumo por tipo de radiofármaco, etc. La mejora en la gestión de pedidos asegura la presencia del radiofármaco necesario para cada exploración. Conclusiones: Estos nuevos cuadros de mando integrales son útiles para optimizar pedidos y radiofármacos, asegurar trazabilidad, gestionar inventario, informes clínicos, residuos radiactivos y para evaluar la eficiencia de la Unidad de radiofarmacia, permitiendo la integración de estos datos con otros softwares de gestión sanitaria. Esta metodología puede aplicarse en Centros Sanitarios de Atención Primaria para enfocar al personal en sus funciones asistenciales y operativas
Objetives: We list the essential variables in Balanced Scorecards to cover all basic areas of work in a Radiopharmacy Hospital Unit, whose proper management can be key in optimizing the resources that are available. Secondly, to list the benefits in the practice of daily work that result after integration. Methods: A review of the published literature about Balanced Scorecards, selecting the variables to be collected for the radiopharmaceutical to take an active role in improving his work area. Applications built in Microsoft Access for comprehensive management are used. They are administered in various modules all the information from the prescription and citation patients (assigning a code) until they perform medical test. Also collected variables such as date and time limits for processing radiopharmaceutical supplier; medical test date; management elutions of generators and cold kits; staff work shifts; typified record incidents and receive data, labeling, quality control and dispensing of each radiopharmaceutical (ensuring traceability); detecting deviations between calibrated and measured activity; to know the dispensed activity and available in real time; management of radioactive waste disposal, inventory and expiration dates; dates of upcoming reviews of equipment; SOP filed; converter systems units and registration of clinical reports. Results: These specialized software manage the information handled in daily practice in Radiopharmacy Hospital Unit, facilitating cost-effective decisions. These parameters analyzed are usually: number of elaborate preparations and managed activity; possible incidents in any of the everyday processes; percentage of satisfactory resolution without resulting in unavailability; correct traceability of radiopharmaceuticals; percentage of satisfactory quality controls; evolution in consumption by type of radiopharmaceutical, etc. The improved order management ensures the presence of the radiopharmaceutical needed for each medical test. Conclusions: These new Balanced Scorecards are useful to optimize orders and radiopharmaceuticals, ensure traceability, inventory management, clinical reports, radioactive waste and to evaluate the efficiency of the Radiopharmacy Hospital Unit, allowing the integration of these data with others software health management. This methodology can be applied in Primary Care Health Centers to focus on its healthcare staff and operational functions
Assuntos
Humanos , Masculino , Feminino , Serviços Comunitários de Farmácia/organização & administração , Serviço de Farmácia Hospitalar/organização & administração , Serviço de Farmácia Hospitalar/normas , Serviço de Farmácia Hospitalar , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Informação em Farmácia Clínica/normas , Software/legislação & jurisprudência , Software/normas , Atenção Primária à Saúde/organização & administração , Atenção Primária à Saúde/normasRESUMO
In a health system increasingly driven by cost constraints, there is a focus on improved electronic transfer of information to support healthcare delivery. One area of healthcare that has moved more quickly than others to achieve this is prescribing in the primary care environment. Whilst the move to electronic transfer of prescriptions has reduced transcription errors, the regulatory environment persists with handwritten signatures. This constraint, whilst addressed slowly with technology solutions, needs support from legislative change. The ultimate step is to have a secure mobile model, which would support the move to a fully-electronic, paperless transaction model.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Segurança Computacional/normas , Confidencialidade/normas , Prescrição Eletrônica/normas , Sistemas de Registro de Ordens Médicas/normas , Sistemas de Medicação/normas , Austrália , Nível Sete de Saúde/normas , Guias de Prática Clínica como AssuntoRESUMO
INTRODUCTION: Pharmacy information system (PIS) is a complex computerized system used for collecting, storing, and managing the medication therapy data in the course of patients' care. The purpose of this study was to evaluate the level of adherence to the standards established by the societies of pharmacists in the PISs employed in the hospitals in Isfahan, Iran. METHODS: The present study was an applied, descriptive-analytical study conducted on the PISs of 19 teaching, private and social insurance hospitals in Isfahan in 2011. Study population consisted of the PISs available in the hospitals under study. Study sample was the same as the study population. The data collection instrument was a self-developed checklist based on the guidelines of the American Society of Health-System Pharmacists and Pharmaceutical Society of Australia, whose validity was assessed and confirmed by expert professors' views. Having been collected by observation and interview methods, data were analyzed by SPSS 18 software using Mann-Whitney statistical test. RESULTS: The findings of the study revealed that the highest rank in adherence to the standards of societies of pharmacists was obtained by social services hospitals (32.75%), while the private hospitals obtained the lowest rank (23.32%). CONCLUSIONS: Based on the findings, in the PISs in the hospitals under study, some standards of the society of pharmacists were ignored. Hence, prior to designing and implementing PIS, a needs analysis is required to increase its users' motivation to identify the system potentialities and to allow the system development in compliance with the world technology advancement.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Sistemas de Apoio a Decisões Clínicas , Fidelidade a Diretrizes , Serviço de Farmácia Hospitalar/normas , Sociedades Farmacêuticas , Sistemas de Informação em Farmácia Clínica/organização & administração , Relações Interprofissionais , Irã (Geográfico) , Farmacêuticos/normas , Serviço de Farmácia Hospitalar/organização & administração , Papel Profissional , Qualidade da Assistência à SaúdeRESUMO
OBJECTIVE: Safety advocates have identified barcode verification technology as an important tool to improve health-care practices. METHODS: We evaluated the evidence for the role of barcode technology in improving a wide range of medication safety outcomes across a broad range of settings. Important implementation issues were highlighted to guide standards for the safe adoption of barcode technology. RESULTS: Adverse drug events are common, occurring frequently in both inpatient and outpatient settings. Although approximately half of all preventable adverse drug events in inpatients result from medication errors arising from transcription, dispensing, and administration, these errors are far less likely to be caught than in any of the earlier stages of the medication use process and are therefore most amenable to improvement. When integrated with electronic medication administration records, barcode systems are associated with complete elimination of transcription errors. Furthermore, barcode-assisted dispensing systems are associated with 93% to 96% reductions in dispensing errors, and 85% reductions in potential adverse drug events in dispensing. Most studies have reported large and significant reductions in administration errors by up to 80% after implementation of barcode medication administration systems. Although most studies of barcode technology have been conducted in the adult inpatient setting, the limited data available also support their benefit in pediatric and outpatient settings. CONCLUSIONS: There is growing evidence for the efficacy of barcode solutions in improving overall medication safety. Standards for the implementation of barcode technology are proposed.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Processamento Eletrônico de Dados/normas , Erros de Medicação/prevenção & controle , Segurança do Paciente , Adulto , Criança , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Garantia da Qualidade dos Cuidados de SaúdeAssuntos
Sistemas de Informação em Farmácia Clínica , Conduta do Tratamento Medicamentoso , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Informação em Farmácia Clínica/normas , Bases de Dados Factuais , Humanos , Relações Interinstitucionais , Internet , Conduta do Tratamento Medicamentoso/organização & administração , Conduta do Tratamento Medicamentoso/normasRESUMO
PURPOSE: An evaluation of a rules-based pharmacotherapy alerting system configured to identify improperly verified new medication orders in an inpatient setting is described. METHODS: A retrospective pre-post cohort study was conducted to assess order-verification alerts and pharmacy interventions at a 900-bed hospital before and after implementation of a commercial pharmacotherapy alerting system. In the preintervention phase of the study, the pharmacotherapy alerting system was used on a limited basis, with clinical pharmacists responding to all alerts and the resulting data used to refine the trigger rules; for the intervention phase, the pharmacotherapy alerting system was programmed to alert only on order-verification errors involving four medications (darbepoetin, filgrastim, fondaparinux, and warfarin). In the event of alerts, a pharmacy response team provided nearly real-time feedback to the order-verification pharmacist, mainly via e-mail or paging. RESULTS: From the preintervention period to the intervention period, there was a 36% decrease in the frequency of order-verification alerts (p = 0.035), and the average number of alerts per day declined from 1.0 to 0.6, suggesting that the pharmacotherapy alerting system and associated oversight mechanisms were effective in enabling pharmacy staff to prevent future errors at the order-verification step before such errors could result in patient harm. The review team spent an average of 10.2 minutes carrying out interventions in response to alerts during the intervention phase. CONCLUSION: Incorporation of a real-time pharmacotherapy alerting system with an oversight response process reduced the number of pharmacotherapy alerts and facilitated interception and prevention of adverse drug events.
Assuntos
Sistemas de Registro de Ordens Médicas/tendências , Erros de Medicação/prevenção & controle , Serviço de Farmácia Hospitalar/tendências , Sistemas de Informação em Farmácia Clínica/normas , Sistemas de Informação em Farmácia Clínica/tendências , Estudos de Coortes , Humanos , Sistemas de Registro de Ordens Médicas/normas , Erros de Medicação/tendências , Serviço de Farmácia Hospitalar/métodos , Serviço de Farmácia Hospitalar/normas , Estudos Retrospectivos , Centros de Atenção Terciária/normas , Centros de Atenção Terciária/tendênciasRESUMO
Objetivo. Determinar la cantidad y calidad de información sobre medicamentos que reciben los pacientes atendidos en un hospital. Método. Estudio descriptivo transversal realizado durante febrero de 2011, mediante diseño de una encuesta y entrevista a 60 pacientes: 30 ingresados y 30 externos. Análisis descriptivo de los resultados: número y grado de conocimiento de los medicamentos respecto al tratamiento «real», analizado de forma global, por edad y por vía de administración. Resultados. En el grupo de pacientes ingresados se analizaron 234 medicamentos «reales». Según los resultados de la encuesta, 45/234 (19,2%; IC95%:14-25) fueron conocidos de forma adecuada por los pacientes. En los pacientes externos esta cifra ascendió a 29/42 (69,0%; IC95%:53-82). El 33,3% de los pacientes verificó su medicación antes de ser administrada o dispensada. Los pacientes ingresados conocían mejor los medicamentos administrados por vía oral: el 28,6% frente al 5,1% de los parenterales. El 45,3% de los ingresados y el 2,4% de los externos desconocían la medicación. La edad media de los pacientes con conocimiento nulo de su medicación fue de 68,5 años (DE=10,1) y tenían 8,7 medicamentos prescritos (DE=3,0). El 53,3% y el 93,3% de los pacientes ingresados y externos respectivamente, consideraban haber sido informado correctamente. El 96,7% dijeron estar satisfechos con la información recibida. Conclusiones. Los resultados obtenidos muestran un potencial de mejora importante respecto a la información que se da a los pacientes, especialmente ingresados, en el hospital. Informarles permitiría su participación como filtro ante posibles errores de medicación y como pieza necesaria para la mejora de la seguridad asistencial(AU)
Objective. To determine the quantity and quality of drug information that patients receive in hospital. Method. Cross-sectional study conducted in February 2011, by designing and conducting a structured questionnaire on 60 patients: 30 inpatients and 30 outpatients. Descriptive analysis of the results was performed including, number and level of knowledge of medication treatment versus the "real" one, globally analysed by age and route of administration. Results. A total of 234 drugs were analysed in the inpatient group. It was considered that 45/234 (19.2%;95% CI: 14-25) were known properly by patients. In outpatients, this rises to 29/42 (69.0%;95% CI: 53-82). One third (33.3%) of patients check the medication before it is administered or provided. Inpatients are more aware of orally administered drugs, they knew 28.6% vs 5.1% of parenteral treatments. Just under half (45.3%) of inpatients and 2.4% of outpatients completely unknown the medication. The average age of patients with no knowledge of their medication was 68.5 years (SD=10.1) and had 8.7 drugs prescribed (SD=3.0). A total of 53.3% of inpatients and 93.3% of outpatients, considered to have been properly informed. Most of patients (96.7%) were satisfied with the information received. Conclusions. The results show an opportunity for improvement in the information given to patients, particularly to inpatients. To inform them, would enable them to act as a filter to potential medication errors, and as a necessary part to improve the safety of care(AU)
Assuntos
Humanos , Masculino , Feminino , Hospitalização/tendências , Seguro de Hospitalização/normas , Seguro de Hospitalização , Serviços de Informação sobre Medicamentos/organização & administração , Serviços de Informação sobre Medicamentos/normas , Serviços de Informação sobre Medicamentos/tendências , Segurança do Paciente/normas , /normas , Sistemas de Informação em Farmácia Clínica/normas , Estudos Transversais/métodos , Estudos Transversais/tendências , /métodos , /tendênciasAssuntos
Sistemas de Informação em Farmácia Clínica/normas , Sistemas de Apoio a Decisões Clínicas/normas , Serviços de Informação sobre Medicamentos/normas , Sistemas de Informação em Farmácia Clínica/organização & administração , Sistemas de Apoio a Decisões Clínicas/organização & administração , Serviços de Informação sobre Medicamentos/organização & administração , Quimioterapia Assistida por Computador/normas , Prescrição Eletrônica/normas , Garantia da Qualidade dos Cuidados de Saúde , SuéciaRESUMO
Medication errors during admission to hospitals pose a significant problem. Most of the severe medication errors may be related to dispensation and administration. The medication errors may be induced by cost savings and staff reduction characterizing the current health care system. The objective of this study is to evaluate whether implementation of tablet computers has potential to enhance the quality assurance and efficiency of the medication dispensing and administration stages. The study is based on a combination of participant observation, structured workshop and qualitative interviews. Data has primary been collected on a Danish hospital ward. The study concludes that the technology still needs to mature before implementation and that there is a constant need for redesign of the technology. However, the results also show that technology has the potential to improve patient safety in the dispensing and administration stages because of an easier control and overview of the medicine paradigm; right patient, right drug, right dose and right time. Additionally, the technology appears to have the potential to streamline work flow in the administration stage due to an improved barcode registration mechanism. However, the potential of a successful implementation depends on prior working routines in the individual hospital ward.
Assuntos
Sistemas de Informação em Farmácia Clínica/normas , Computadores de Mão/normas , Erros de Medicação/prevenção & controle , Sistemas de Medicação no Hospital/normas , Garantia da Qualidade dos Cuidados de Saúde/normas , Interface Usuário-Computador , DinamarcaRESUMO
Introducción: Un cambio de programa informático es un factor de riesgo de errores de prescripción farmacológica. Nuestro objetivo fue evaluar la eficacia de medidas preventivas para evitar estos errores en nuestro centro. Material y métodos: En el año 2007 (período 1), ante un futuro cambio de programa informático, se realizó un estudio de los errores de tratamiento y se diseñó un plan de prevención. Se clasificaron los errores según el tipo (indicación, dosis, vía de administración), la gravedad y los factores asociados a errores (nivel de urgencia, edad del paciente, experiencia del facultativo, día de la semana y hora del día). Tras la implantación del nuevo programa (año 2009) (período 2) se reevaluaron los mismos parámetros y se compararon con el período previo. Se realizó una revisión retrospectiva de todos los informes donde constaba algún tratamiento administrado en urgencias la misma semana y mes de ambos períodos. Resultados: En el período 1 se realizaron 615 prescripciones con errores en 92 (15%) y en el período 2, 445 con 51 (11,5%) errores, sin diferencias significativas entre ambos. Se observó una disminución significativa de errores de indicación inapropiada (8,1% período 1 vs 3,6% período 2; p=0,04) sin diferencias en los de dosis, vía de administración y gravedad del error. Se redujeron de forma significativa los errores en los facultativos de mayor experiencia y aumentaron en los rotantes externos (que no recibieron formación en el funcionamiento del nuevo programa). Conclusiones: El conocimiento de la situación previa y la aplicación de medidas preventivas permitieron que no aumentaran los errores con un nuevo programa informático(AU)
Introduction: Changing the computer software is a known risk factor of increased prescription drug errors. The aim of this study was to evaluate the effectiveness of preventive measures to prevent these errors at our centre. Material and methods: In 2007 (period 1), knowing that a change of computer software was coming, a study to determine the prescription drug errors was performed and an improvement plan was designed. Errors were classified as: type of error (indication, dosage, route of administration), severity and associated risk factors (emergency level, patient age, physician experience, day of week, time of day). Following the introduction of the new computer software (year 2009) (period 2), the same parameters were re-evaluated and compared with the previous period. All Paediatric Emergency Department (PED) reports, where some treatment was administered in the Emergency room in the same week and month for both periods, were reviewed. Results: A total of 615 prescriptions were written during period 1, of which 92 (15%) were classified as errors, and in period 2, 445 were written and 51 (11.5%) had errors, with no significant differences between both periods. There was a significant decrease in inappropriate indication errors (8.1% in period 1 vs 3.6% in period 2; P=.04), with no differences in dosage, route of administration and severity of errors. There was a significant error reduction in more experienced physicians, and an increase in errors by external rotation physicians (who were not skilled in the use of the new program). Conclusions: The knowledge of the previous situation and the use of preventive measures ensured that errors did not increase after a change of computer software(AU)